345 related articles for article (PubMed ID: 16253464)
1. The application of LC-NMR and LC-MS for the separation and rapid structure elucidation of an unknown impurity in 5-aminosalicylic acid.
Novak P; Tepes P; Fistrić I; Bratos I; Gabelica V
J Pharm Biomed Anal; 2006 Mar; 40(5):1268-72. PubMed ID: 16253464
[TBL] [Abstract][Full Text] [Related]
2. LC-NMR and LC-MS identification of an impurity in a novel antifungal drug icofungipen.
Novak P; Tepes P; Ilijas M; Fistrić I; Bratos I; Avdagić A; Hamersak Z; Marković VG; Dumić M
J Pharm Biomed Anal; 2009 Aug; 50(1):68-72. PubMed ID: 19410412
[TBL] [Abstract][Full Text] [Related]
3. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of process related impurities in chloroquine and hydroxychloroquine by LC/IT/MS, LC/TOF/MS and NMR.
Dongre VG; Ghugare PD; Karmuse P; Singh D; Jadhav A; Kumar A
J Pharm Biomed Anal; 2009 May; 49(4):873-9. PubMed ID: 19201565
[TBL] [Abstract][Full Text] [Related]
5. Structural elucidation of a process-related impurity in ezetimibe by LC/MS/MS and NMR.
Raman B; Sharma BA; Butala R; Ghugare PD; Kumar A
J Pharm Biomed Anal; 2010 May; 52(1):73-8. PubMed ID: 20079995
[TBL] [Abstract][Full Text] [Related]
6. Application of LC-MS(n) in conjunction with mechanism-based stress studies in the elucidation of drug impurity structure: rapid identification of a process impurity in betamethasone 17-valerate drug substance.
Li M; Lin M; Rustum A
J Pharm Biomed Anal; 2008 Dec; 48(5):1451-6. PubMed ID: 18977106
[TBL] [Abstract][Full Text] [Related]
7. Nuclear magnetic resonance and liquid chromatography-mass spectrometry combined with an incompleted separation strategy for identifying the natural products in crude extract.
Dai D; He J; Sun R; Zhang R; Aisa HA; Abliz Z
Anal Chim Acta; 2009 Jan; 632(2):221-8. PubMed ID: 19110097
[TBL] [Abstract][Full Text] [Related]
8. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
[TBL] [Abstract][Full Text] [Related]
9. Preparative isolation and structural elucidation of impurities in fluconazole by LC/MS/MS.
Dongre VG; Karmuse PP; Ghugre PD; Salunke SM; Panda N; Kumar A
J Pharm Biomed Anal; 2006 Sep; 42(3):334-40. PubMed ID: 16757140
[TBL] [Abstract][Full Text] [Related]
10. Identification and structural elucidation of an unknown impurity in carbamazepine active pharmaceutical ingredient by liquid chromatography-tandem mass spectrometry and semi-preparative chromatographic isolation.
Thomas S; Mathela CS; Agarwal A; Paul SK
J Pharm Biomed Anal; 2011 Sep; 56(2):423-8. PubMed ID: 21676571
[TBL] [Abstract][Full Text] [Related]
11. Investigation of amodiaquine bulk drug impurities by liquid chromatography/ion trap mass spectrometry.
Dongre VG; Karmuse PP; Ghugare PD; Kanojiya SK; Rawal S
Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2227-33. PubMed ID: 18543378
[TBL] [Abstract][Full Text] [Related]
12. LC-UV-solid-phase extraction-NMR-MS combined with a cryogenic flow probe and its application to the identification of compounds present in Greek oregano.
Exarchou V; Godejohann M; van Beek TA; Gerothanassis IP; Vervoort J
Anal Chem; 2003 Nov; 75(22):6288-94. PubMed ID: 14616013
[TBL] [Abstract][Full Text] [Related]
13. Identification of unknown impurities in simvastatin substance and tablets by liquid chromatography/tandem mass spectrometry.
Vuletić M; Cindrić M; Koruznjak JD
J Pharm Biomed Anal; 2005 Apr; 37(4):715-21. PubMed ID: 15797793
[TBL] [Abstract][Full Text] [Related]
14. On-line identification of phenanthroindolizidine alkaloids in a crude extract from Tylophora atrofolliculata by liquid chromatography combined with tandem mass spectrometry.
Cui L; Abliz Z; Xia M; Zhao L; Gao S; He W; Xiang Y; Liang F; Yu S
Rapid Commun Mass Spectrom; 2004; 18(2):184-90. PubMed ID: 14745768
[TBL] [Abstract][Full Text] [Related]
15. Investigation and structural elucidation of a process related impurity in candesartan cilexetil by LC/ESI-ITMS and NMR.
Raman B; Sharma BA; Mahale G; Singh D; Kumar A
J Pharm Biomed Anal; 2011 Sep; 56(2):256-63. PubMed ID: 21664089
[TBL] [Abstract][Full Text] [Related]
16. Application of NMR spectroscopy and LC-NMR/MS to the identification of carbohydrates in beer.
Duarte IF; Godejohann M; Braumann U; Spraul M; Gil AM
J Agric Food Chem; 2003 Aug; 51(17):4847-52. PubMed ID: 12903934
[TBL] [Abstract][Full Text] [Related]
17. Strategy for identification of leachables in packaged pharmaceutical liquid formulations.
Pan C; Harmon F; Toscano K; Liu F; Vivilecchia R
J Pharm Biomed Anal; 2008 Feb; 46(3):520-7. PubMed ID: 18180126
[TBL] [Abstract][Full Text] [Related]
18. Online hyphenated liquid chromatography-nuclear magnetic resonance spectroscopy-mass spectrometry for drug metabolite and nature product analysis.
Yang Z
J Pharm Biomed Anal; 2006 Feb; 40(3):516-27. PubMed ID: 16280226
[TBL] [Abstract][Full Text] [Related]
19. Identification of a new impurity in lisinopril.
Shinde V; Trivedi A; Upadhayay PR; Gupta NL; Kanase DG; Chikate R
J Pharm Biomed Anal; 2007 Jan; 43(1):381-6. PubMed ID: 16926080
[TBL] [Abstract][Full Text] [Related]
20. Separation and analysis of trace degradants in a pharmaceutical formulation using on-line capillary isotachophoresis-NMR.
Eldridge SL; Almeida VK; Korir AK; Larive CK
Anal Chem; 2007 Nov; 79(22):8446-53. PubMed ID: 17929948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
